Litcius/Paper detail

Treatment of methicillin-resistant <i>Staphylococcus aureus</i> (MRSA): updated guidelines from the UK

Nicholas M Brown, Anna L. Goodman, Carolyne Horner, Abi Jenkins, Erwin Brown

2021JAC-Antimicrobial Resistance182 citationsDOIOpen Access PDF

Abstract

These evidence-based guidelines are an updated version of those issued in 2008. They have been produced following a review of the published literature (2007-18) pertaining to the treatment of infections caused by MRSA. The guidelines update, where appropriate, previous recommendations, taking into account changes in the UK epidemiology of MRSA, ongoing national surveillance data and the efficacy of novel anti-staphylococcal agents licensed for use in the UK. Emerging therapies that have not been licensed for use in the UK at the time of the review have also been assessed.

Topics & Concepts

Staphylococcus aureusMethicillin-resistant Staphylococcus aureusMicrobiologyMedicineBiologyBacteriaGeneticsAntimicrobial Resistance in StaphylococcusBacterial Identification and Susceptibility TestingStreptococcal Infections and Treatments
Treatment of methicillin-resistant <i>Staphylococcus aureus</i> (MRSA): updated guidelines from the UK | Litcius